Tetra Bio Pharma (QB) Stock Price - TBPMF

0.167
0.007 (4.37%)
0.167
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Tetra Bio Pharma Inc (QB) TBPMF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.007 4.37% 0.167 0.1578 0.1718 0.17125 0.16 16:00:06
Bid Price Ask Price Spread Spread % News
0.154 0.169 0.015 8.88% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
61 130,331 $ 0.162744 $ 21,211 150,149 0.139 - 0.6045
Last Trade Time Type Quantity Stock Price Currency
15:59:47 1,000 $ 0.167 USD

Tetra Bio Pharma (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 41.19M 246.64M 204.69k $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
322.88k $ - 0.00% - -

more financials information »

Tetra Bio Pharma (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TBPMF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.170.1740.1450.1566895165,836-0.003-1.76%
1 Month0.22450.250.1450.1716142192,272-0.0575-25.61%
3 Months0.17520.2770.140.1855408139,243-0.0082-4.68%
6 Months0.39510.60450.140.286829169,297-0.2281-57.73%
1 Year0.467460.60450.1390.2744874126,669-0.30046-64.28%
3 Years0.74321.410.1390.5209590,552-0.5762-77.53%
5 Years0.0241.410.00620.508339486,4810.143595.83%

Tetra Bio Pharma (QB) Description

Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a diversified and multifaceted bio-pharmaceutical company with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. The company operates in two business segments which are biopharmaceutical and natural health. The biopharmaceutical segment aims at development of cannabinoid-based medicines in three areas: Ophthalmology (treatment of eye diseases), Chronic pain and Oncology. The natural health segment aims at the development and marketing of hemp or non-cannabinoid-based natural health products, or cannabinoid-based products authorized for sale over the counter (OTC) by Health Canada.


Your Recent History
USOTC
TBPMF
Tetra Bio ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.